Sad but, unfortunately true, losing confidence in gils ability to see the future clearly. Remember the 90 day trial? Tox knew it was a 4 year trial before any kind of results would be had, if it was even allowed to enter into a clinical trial.
Hi there survtech
Load the boat now, no r/s, this was a take down by purpose. Difference in opinions and timing for an add on offering of 75 mil. Someone wanted to make sure it didn't go off until 8040 results (actual individual patient efficacy) could be presented
Big show is coming soon
Yes, if the PMDA approves the trial and then by 2020 the trial will be completed. Hopefully better than the last gilly disaster 😝
Tox did, more like November 2016 with the larger trial gilly now is required to run
Pumpers told you 90 days, small proof trial and $10.00 a share
Larger trial will satisfy the PMDA, larger trial means more IRB approvals and training. November would be the earliest approval from a participating trial site.
With gilly's fables and the britshit issue, ATHX is more likely to hit $1.50 - $1.60 by November
Athersyss, toxicblumper, survpro, unemom and all the lemming faithful
Teva and MESO parting ways, if Japan's PMDA even flinches, ATHX will be back to $1.20 before you can say gilly
Investors and traders will sit it out until they hear from Healios
He's obsessed with my ability to call the direction of a stock. Maybe some type of pseudo sexual stock envy?
And fear not, even though we do have the K girl on our side, trial sites should be collecting 8040 data from the phase 2a expansion portion of the trial this month and submitting for final analysis.
38% Remission in relapsed / refractory patients in fantastic! The big question is how long did the remission last? Also if they did find another subset that is responding, it will only get better for BLRX.
The current share price is not indicative of failure or success, many traders don't want to risk the big nut while other new traders as picking up cheap shares willing to roll the dice.